Relationship between drug/metabolite exposure and impairment of excretory transport function

Drug Metabolism and Disposition

Volumn 37, Issue 2, 2009, Pages 386-390

  Zamek Gliszczynski, Maciej J ^a   Kalvass, J Cory ^a   Pollack, Gary M ^b   Brouwer, Kim L R ^b  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; XENOBIOTIC AGENT;

ARTICLE; CLEARANCE; CONCEPTUAL FRAMEWORK; DRUG CLEARANCE; DRUG EXCRETION; DRUG EXPOSURE; INHIBITION KINETICS; INTESTINE; KIDNEY; LIVER; MATHEMATICAL ANALYSIS; METABOLITE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RODENT;

ANIMALS; BIOLOGICAL TRANSPORT; COMPUTATIONAL BIOLOGY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY;

RODENTIA;

EID: 59649106641     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023648     Document Type: Article

References (16)

1. Adachi Y, Okuyama Y, Miya H, Matsusita H, Kitano M, Kamisako T, and Yamamoto T (1996) Pravastatin transport across the hepatocyte canalicular membrane requires both ATP and a transmembrane pH gradient. J Gastroenterol Hepatol 11:580-585.
2. Chen C, Scott D, Hanson E, Franco J, Berryman E, Volberg M, and Liu X (2003) Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats. Pharm Res 20:31-37.
3. Chiba M and Pang KS (1993) Effect of protein binding on 4-methylumbelliferyl sulfate desulfation kinetics in perfused rat liver. J Pharmacol Exp Ther 266:492-499.
4. HiranoM,MaedaK,ShitaraY,andSugiyamaY(2004)ContributionofOATP2(OATP1B1)and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther 311:139-146.
5. -rats. Drug Metab Dispos 33:1593-1596.
6. Liu L and Pang KS (2006) An integrated approach to model hepatic drug clearance. Eur J Pharm Sci 29:215-230.
7. Mizuno N, Suzuki M, Kusuhara H, Suzuki H, Takeuchi K, Niwa T, Jonker JW, and Sugiyama Y (2004) Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2- methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. Drug Metab Dispos 32:898-901.
8. Nezasa K, Tian X, Zamek-Gliszczynski MJ, Patel NJ, Raub TJ, and Brouwer KLR (2006) Altered hepatobiliary disposition of 5 (and 6)-carboxy-2′, 7′-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice. Drug Metab Dispos 34:718-723.
9. Rowland M and Matin SB (1973) Kinetics of drug-druginteractions. JPharmacokinetBiopharm 1:553-567.
10. Sasaki M, Suzuki H, Ito K, Abe T, and Sugiyama Y (2002) Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem 277:6497-6503.
11. Takenaka O, Horie T, Kobayashi K, Suzuki H, and Sugiyama Y (1995) Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia. Pharm Res 12:1746-1755.
12. Ueda K, Kato Y, Komatsu K, and Sugiyama Y (2001) Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data. J Pharmacol Exp Ther 297:1036- 1043.
13. Xiong H, Suzuki H, Sugiyama Y, Meier PJ, Pollack GM, and Brouwer KLR (2002) Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment. Drug Metab Dispos 30:962-969.
14. Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K, Tallman MN, and Brouwer KLR (2006a) Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci 27:447-486.
15. -/- mice. J Pharmacol Exp Ther 319:1485-1491.
16. Zamek-Gliszczynski MJ, Nezasa K, Tian X, Kalvass JC, Patel NJ, Raub TJ, and Brouwer KLR (2006c) The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice. Mol Pharmacol 70:2127-2133.